Human equilibrative nucleoside transporter 1 is not predictive for gemcitabine efficacy in advanced pancreatic cancer: translational results from the AIO-PK0104 phase III study with the clone SP120 rabbit antibody.
Eur J Cancer
; 50(11): 1891-9, 2014 Jul.
Article
in En
| MEDLINE
| ID: mdl-24857044
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pancreatic Neoplasms
/
Antineoplastic Combined Chemotherapy Protocols
/
Biomarkers, Tumor
/
Equilibrative Nucleoside Transporter 1
Type of study:
Clinical_trials
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Adolescent
/
Adult
/
Aged
/
Animals
/
Humans
/
Middle aged
Language:
En
Journal:
Eur J Cancer
Year:
2014
Document type:
Article
Affiliation country:
Country of publication: